Massive study tracks Long-Term risks for rare gut condition

This study is a large, long-term registry that aims to understand the safety and real-world outcomes for people living with short bowel syndrome. It will follow over 1,800 participants, including those who are and are not treated with the medication teduglutide, to track health events like cancer, intestinal problems, and treatment side effects over time. The goal is to gather knowledge about the long-term course of the disease and the safety of its treatment in everyday clinical practice.